TPVG trades at 0.74x book with a 14% yield, but PIK and 2026 refinancing risks threaten NII and a dividend cut.

In other recent news, TriplePoint Venture Growth BDC Corp reported its third-quarter 2025 earnings, which did not meet analyst expectations. The company announced an earnings per share (EPS) of $0.26, ...

TriplePoint Venture Growth BDC Corp (NASDAQ:TPVG) CEO James Labe reported purchasing shares of common stock in two transactions totaling $361,810. The purchases occurred on December 8 and December 9, ...

In other recent news, TriplePoint Venture Growth BDC Corp reported its third-quarter 2025 earnings, revealing an earnings per share (EPS) of $0.26, which was below the forecasted $0.29. The company’s ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

About TriplePoint Venture Growth BDC Corp. TriplePoint Venture Growth BDC Corp. is a traded business development company that seeks investment opportunities in companies located across the globe ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

CoreWeave, Inc. Chief Development Officer Brannin McBee conducted multiple sales on December 29, 2025, totaling over $12.6 million. The transactions included sales at prices ranging from $73.84 to $77 ...

Retatrutide works by mimicking three hunger-regulating hormones. A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising ...